- $3.23bn
- $4.03bn
- $1.52bn
- 91
- 91
- 91
- 100
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 693 | 747 | 620 | 1,443 | 1,520 |
Cost of Revenue | |||||
Gross Profit | 425 | 519 | 379 | 984 | 1,090 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 487 | 608 | 618 | 842 | 822 |
Operating Profit | 206 | 139 | 1.4 | 601 | 699 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 167 | 89.5 | -40.7 | 557 | 652 |
Provision for Income Taxes | |||||
Net Income After Taxes | 166 | 88.1 | -42.1 | 563 | 648 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 166 | 88.1 | -42.1 | 563 | 648 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 166 | 88.1 | -42.1 | 563 | 648 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.694 | 1.64 | -0.491 | 6.81 | 7.02 |
Dividends per Share |